DNMT1 and hepatocellular carcinoma: Similarly, Kogure et al. found that miR-29a inhibited DNMT1 and DNMT3B to counteract the increased expression levels of EMT marker E-cadherin induced by TGF-β in PLC/PRF/5 hepatoma cells [50].